The device is used as an aid 1)in the diagnosis of persons with symptoms or risk factors for transitional cell cancer (tcc) of the bladder (cut-off >= 7. 5u/ml) in conjunction with and not in lieu of current standard diagnostic procedures and 2) in the management of patients with transitional cell carcinoma of the bladder, after surgical treatment to identify those patients with occult or rapidly recurring tcc (cut-off >10u/ml).
Device | MATRITECH NMP22 TEST KIT |
Classification Name | System, Test, Tumor Marker, For Detection Of Bladder Cancer |
Generic Name | System, Test, Tumor Marker, For Detection Of Bladder Cancer |
Applicant | ALERE SCARBOROUGH, INC |
Date Received | 1999-07-23 |
Decision Date | 2000-01-18 |
Notice Date | 2000-09-21 |
PMA | P940035 |
Supplement | S002 |
Product Code | NAH |
Docket Number | 00M-1522 |
Advisory Committee | Immunology |
Supplement Type | Panel Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | ALERE SCARBOROUGH, INC 10 Southgate Road scarborough, ME 04074 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling |
Approval Order: | Approval Order |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P940035 | | Original Filing |
S017 |
2022-02-08 |
Normal 180 Day Track No User Fee |
S016 |
2021-05-27 |
30-day Notice |
S015 |
2018-04-18 |
30-day Notice |
S014 |
2017-01-30 |
30-day Notice |
S013 |
2016-08-16 |
30-day Notice |
S012 |
2016-04-06 |
30-day Notice |
S011 |
2015-07-01 |
30-day Notice |
S010 |
2013-07-10 |
Special (immediate Track) |
S009 |
2013-03-18 |
30-day Notice |
S008 |
2010-11-22 |
Normal 180 Day Track No User Fee |
S007 |
2011-07-27 |
Normal 180 Day Track No User Fee |
S006 |
2011-05-11 |
Normal 180 Day Track No User Fee |
S005 |
2008-05-16 |
Normal 180 Day Track No User Fee |
S004 |
2008-03-27 |
Normal 180 Day Track No User Fee |
S003 |
2002-09-16 |
Normal 180 Day Track |
S002 |
1999-07-23 |
Panel Track |
S001 |
1996-12-16 |
Normal 180 Day Track |
NIH GUDID Devices